Acute hepatitis complicating intravenous amiodarone treatment

Italian Heart Journal

Volumn 3, Issue 11, 2002, Pages 686-688

  Agozzino, Francesco ^a   Picca, Maurizio ^a   Pelosi, Giancarlo ^a  

^a FATEBENEFRATELLI HOSPITAL   (Italy)

Author keywords

Artrial fibrillation; Cardioversion; Hepatic disease

Indexed keywords

ALANINE AMINOTRANSFERASE; AMIODARONE; ASPARTATE AMINOTRANSFERASE; FUROSEMIDE; HEPARIN;

ACUTE HEPATITIS; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOLYSIS; DISEASE SEVERITY; DRUG INDUCED DISEASE; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FAILURE; HOSPITAL ADMISSION; HUMAN; JAUNDICE; LIVER CELL DAMAGE; LIVER DISEASE; LIVER DYSFUNCTION; LIVER TOXICITY; SYMPTOMATOLOGY; TOXIC HEPATITIS;

ACUTE DISEASE; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; FEMALE; HEPATITIS, TOXIC; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; LIVER FUNCTION TESTS;

EID: 0036874536     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mason JW. Amiodarone. N Engl J Med 1987; 19: 455-66.
2. Heger JJ, Prystowsky EN, Jackman WM, et at. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med 1981; 305: 539-45.
3. McGovern B, Garan H, Kelly E, Ruskin JN. Adverse reactions during treatment with amiodarone hydrochloride. BMJ 1983; 287: 175-80.
4. Harris L, McKenna WJ, Rowland E, Holt DW, Storey GC, Krikler DM. Side effects of long-term amiodarone therapy. Circulation 1983; 67: 45-51.
5. Fogoros RN, Anderson KP, Winkle RA, Swerdlow CD, Mason JW. Amiodarone: clinical efficacy and toxicity in 96 patients with recurrent, drug-refractory arrhythmias. Circulation 1983; 68: 88-94.
6. Plomteux G, Heusghem C, Ernould H, Vandeghen N. Long-term hepatic tolerance of amiodarone in the clinic. Eur J Pharmacol 1969; 8: 369-76.
7. Rumessen JJ. Hepatotoxicity of amiodarone. Acta Med Scand 1986; 219: 235-9.
8. Gay G, Netter P, Tréchot P, Roche JP, Zannad F. A case of amiodarone-induced hyperthyroidism and hepatitis: results of clinical laboratory and histological tests. Biomed Pharmacother 1986; 40: 54-7.
9. Lim PK, Trewby PN, Storey GC, Holt DW. Neuropathy and fatal hepatitis in a patient receiving amiodarone. BMJ 1984; 288: 1638-9.
10. Morse RM, Valenzuela GA, Greenwald TP, Eulie PJ, Wesley RC, McCallum RW. Amiodarone-induced liver toxicity. Ann Intern Med 1988; 109: 838-40.
11. Poucell S, Ireton J, Valencia-Mayoral P, et al. Amiodarone-associated phospholipidosis and fibrosis of the liver. Light, immunohistochemical and electron microscopic studies. Gastroenterology 1984; 86: 926-36.
12. Simon JB, Manley PN, Brien JF, Armstrong PW. Amiodarone hepatotoxicity simulating alcoholic liver disease. N Engl J Med 1984; 311: 167-72.
13. Yagupsky P, Gazala E, Sofa S, Maor E, Abarbanel J. Fatal hepatic failure and encephalopathy associated with amiodarone therapy. J Pediatr 1985; 107: 967-70.
14. Lupon-Roses J, Simo-Canonge R, Lu Cortez L, Permanyer-Miralda G, Allende-Monclus H. Probable early acute hepatitis with parenteral amiodarone. Clin Cardiol 1986; 9: 223-5.
15. Pye M, Northcote RJ, Cobbe SM. Acute hepatitis after parenteral amiodarone administration. Br Heart J 1988; 59: 690-1.
16. Kalantzis N, Gabriel P, Mouzas J, Tiniakos D, Tsigas D, Tiniakos G. Acute amiodarone-induced hepatitis. Hepatogastroenterology 1991; 38: 71-4.
17. Morelli S, Guido V, De Marzio P, Aguglia F, Balsano F. Early hepatitis during intravenous amiodarone administration. Cardiology 1991; 78: 291-4.
18. Simon JP, Zannad F, Trechot P, Thisse JY, Houplon M, Aliot E. Acute hepatitis after a loading dose of intravenous amiodarone. Cardiovasc Drugs Ther 1990; 4: 1467-8.
19. Rhodes A, Eastwood JB, Smith SA. Early acute hepatitis with parenteral amiodarone: a toxic effect of the vehicle? Gut 1993; 34: 565-6.
20. James PR, Hardman SM. Acute hepatitis complicating parenteral amiodarone does not preclude subsequent oral therapy. Heart 1997; 77: 583-4.
21. Grech-Bëlanger O. Depressive effect of amiodarone on hepatic drug metabolism in the rat. Res Commun Chem Pathol Pharmacol 1984; 44: 15-30.
22. Varma RR, Troup PJ, Komorowski RA, Sarna T. Clinical and morphologic effects of amiodarone on the liver. (letter) Gastroenterology 1985; 88: 1091.
23. Poucell S, Ireton J, Valencia-Mayoral P, et al. Clinical and morphologic effects of amiodarone on the liver. (letter) Gastroenterology 1985; 88: 1092.
24. Shepherd NA, Dawson AM, Crocker PR, Levison DA. Granular cells as a marker of early amiodarone hepatotoxicity: a pathological and analytical study. J Clin Pathol 1987; 40: 418-23.
25. Jain D, Bowlus CL, Anderson JM, Robert ME. Granular cells as a marker of early amiodarone hepatotoxicity. J Clin Gastroenterol 2000; 31: 241-3.
26. Ruter HD. The E-ferol syndrome solved? In: Dukes MNG, Beeley L, eds. Side effects of drugs, annual 12: a worldwide survey of new data and trends. Amsterdam: Elsevier, 1988: 329.